Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

about

Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis.Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance.

P2860

Q42784235-9B952335-EA18-40D6-98EA-182D6B4534AE Q47136788-93A8B9FA-46DB-449B-B672-5EF0B8D8981A

P2860

Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

Item

http://www.wikidata.org/entity/Q36382083

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

@ast

Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

@en

type

Item

label

Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

@ast

Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

@en

prefLabel

Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

@ast

Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

@en

P1476

Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

@en

P2093

Andrea M Clarke

http://www.w3.org/2001/XMLSchema#string

Annam Abbasi

http://www.w3.org/2001/XMLSchema#string

Lawrence A Scheving

http://www.w3.org/2001/XMLSchema#string

Mary C Stevenson

http://www.w3.org/2001/XMLSchema#string

William E Russell

http://www.w3.org/2001/XMLSchema#string

Xiuqi Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

NIH Image to ImageJ: 25 years of image analysis

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90

Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling

Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype

The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling

Diverse expression of ErbB receptor proteins during rat liver development and regeneration

Dexamethasone modulates ErbB tyrosine kinase expression and signaling through multiple and redundant mechanisms in cultured rat hepatocytes

A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma.

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.

P304

G942-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.00089.2015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

309

http://www.w3.org/2001/XMLSchema#string

P50

David W. Threadgill

Michael A Weintraub

P577

2015-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26492920

http://www.w3.org/2001/XMLSchema#string

P932

4683301

http://www.w3.org/2001/XMLSchema#string

Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

about

P2860

P2860

Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932